FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynlonta (loncastuximab tesirine-lpyl) for the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after… Read More: FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse… »

Are you compensating for your loved one’s hearing loss?

If your loved one has untreated hearing loss and you find yourself constantly having to “translate” (explaining to them what they misheard), you may be compensating for them. Although you’re trying to be helpful, in the long run, compensating can be harmful to both of you. Compensating for your partner’s hearing loss can be mentally draining. “When it… Read More: Are you compensating for your loved one’s hearing loss? »

  1. Pages:
  3. 1
  5. 104
  6. 105
  7. 106
  8. 107
  9. 108
  10. 109
  11. 110
  13. 1261